Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Case Presentations: Pre-Invasive Cervical Neoplasia Kathleen M. Schmeler, M.D. Assistant Professor Department of Gynecologic Oncology Case #1 • 25 yo • Smokes 1 pack of cigarettes per day • Routine Pap test: high-grade squamous intraepithelial lesion (HSIL) • Next step? Case #1 • Cervical biopsy: CIN 3 • Endocervical curettage: CIN 3 CIN 2/3 • 5% of women undergoing Pap tests in the USA • Typically diagnosed between age 25 and 35 years • Progresses to cancer 8 to 13 years after a diagnosis of CIN 2/3 • Caused by persistent infection with high-risk HPV subtypes • HPV infection is necessary but not sufficient to develop CIN 2/3 CIN 2/3 Co-Factors • HIV infection • Immunosuppressive therapy (renal transplant, chemotherapy) • Cigarette smoking Case #1 • Treatment for CIN 2/3? Cervical Conization 1. Cold knife conization (CKC) 2. Loop electrosurgical procedure (LEEP), also known as large loop excision of the transformation zone (LLETZ) 3. Laser conization ** Hysterectomy should not be performed as the initial treatment for CIN 2/3 Complications of LEEP/CKC • • • • • Intraoperative or postoperative bleeding Infection Cervical stenosis Infertility Pregnancy loss/Preterm birth: - CKC = 14% preterm birth rate - LEEP = 11% preterm delivery rate Prognosis Untreated CIN 3: • Risk of cancer is 20% at 10 years and 31% at 30 years Treated CIN 3: • Risk of cancer is 0.3% at 10 years and 0.7% at 30 years McCredie et al., Lancet Onc, 2008 Hysterectomy • Hysterectomy should NOT be performed as initial treatment for CIN 2/3 • Hysterectomy indicated if: - Positive margins for CIN 2/3 and repeat excision not technically possible - Cervix/vagina scarring limiting follow-up exam - Persistent/recurrent CIN 2/3 * Consider frozen cone before hysterectomy if positive margins Case #1 • What if patient were pregnant with CIN3? Pregnancy • • • • • • Do NOT treat CIN 2/3 during pregnancy Perform excision only if cancer suspected Up to 70% regress in postpartum period Significant bleeding and risk of preterm labor if treated during pregnancy ECC should never be performed during pregnancy Repeat cytology and colposcopy 6 to 12 weeks postpartum Case #2 • 45 yo • Routine Pap test shows atypical glandular cells? • Work-up? Case #2 • Colposcopy: negative • Endocervical curettage: adenocarcinoma-insitu • Endometrial biopsy: negative • Next steps? Case #2 • Cone biopsy: adenocarcinoma-in-situ with positive margins • Next steps? Case #2 • Repeat cone biopsy: no residual disease • Next step? Case #2 • Hysterectomy: no residual disease Adenocarcinoma-in-Situ (AIS) • • • • • Atypical glandular cells without invasion Precursor to adenocarcinoma of the cervix (25% of cervical cancers) HPV infection is required (similar to squamous lesions) 10 - 13% of patients have multi-focal disease (“skip lesions”) 50% of patients have concomitant squamous dysplasia or cancer Adenocarcinoma-in-Situ (AIS) • • • Recommend CKC over LEEP due to higher probability of negative margins and no thermal artifact Standard treatment for AIS is hysterectomy once child-bearing is complete If positive cone margins, recommend repeat cone prior to hysterectomy to reduce the possibility of missing an occult cancer and performing incorrect procedure Thank You